{"name":"Universiti Kebangsaan Malaysia Medical Centre","slug":"universiti-kebangsaan-malaysia-medical-centre","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Dexamethasone, granisetron & palonosetron","genericName":"Dexamethasone, granisetron & palonosetron","slug":"dexamethasone-granisetron-palonosetron","indication":"Other","status":"marketed"},{"name":"Oral estradiol valerate","genericName":"Oral estradiol valerate","slug":"oral-estradiol-valerate","indication":"Other","status":"phase_2"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Latanoprost/Timolol","genericName":"Latanoprost/Timolol","slug":"latanoprost-timolol","indication":"Open-angle glaucoma","status":"marketed"}]}],"pipeline":[{"name":"Dexamethasone, granisetron & palonosetron","genericName":"Dexamethasone, granisetron & palonosetron","slug":"dexamethasone-granisetron-palonosetron","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Latanoprost/Timolol","genericName":"Latanoprost/Timolol","slug":"latanoprost-timolol","phase":"marketed","mechanism":"Latanoprost reduces intraocular pressure by increasing uveoscleral outflow of aqueous humor, while timolol decreases aqueous humor production via beta-adrenergic receptor antagonism.","indications":["Open-angle glaucoma","Ocular hypertension"],"catalyst":""},{"name":"Oral estradiol valerate","genericName":"Oral estradiol valerate","slug":"oral-estradiol-valerate","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOYmFPOThmNDlBNTVXUmEwVkFNRmRmM0JkS0s5TjdESVdTdjVUalhrUW9NVFFmNUVaa1J6c01nYlhrYll4bDlnclRHcGxLYWJnUkZxVzBQSG45TjlVX0pPN1JtU052VVhMUUt5N1RHajdOS0RZaTlHTzJETmQ3ZS1TLWFGOXFKakp2U1JTcjd3M1o0Y0ZvUmpZ?oc=5","date":"2025-09-25","type":"pipeline","source":"CodeBlue","summary":"Think Health, Think Pharmacist — Prof Long Chiau Ming - CodeBlue","headline":"Think Health, Think Pharmacist — Prof Long Chiau Ming","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQVHJIbnJwZ2RXOXNpYm9fZ1lmRWMyVHVrUjBRV0t1V21HeE0wWFJrWUt2bzZzeXJKekQ5ZWkzTVcyLWgyYUhhNnR2cUVLVDhSd0xKSkw2VllaWkF4ZXdLb1NpcXgzRV8tcEJuNnlrcV9EN1RRNGFMZkJYNmQtcTczNTJIbERRTWJKVlNxQzJzM2NLbXVlOVlOU2V2QmUzQQ?oc=5","date":"2025-09-09","type":"pipeline","source":"Salaam Gateway","summary":"Halal pharmaceuticals offer rare chance at global harmonization - Salaam Gateway","headline":"Halal pharmaceuticals offer rare chance at global harmonization","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOQ0lYSVgyYW41aTd2RDg5cWdWS2hNQmhCcFkyek11dlBDZjhHcE5XWnZfeE8tZnUwbHU0SF9Odi1WZEx3VVFULUwxNHlFNVZUdTN2NUhuX3JDSGtIQ1BMSjVtZTJQZnJGTGI1UUQ5dFFiOFdleGJGb3o5d2NMZDhrTWdIRHBTcHhFc1hVQTNsT0F5N0RIVDZOYkt1LTA?oc=5","date":"2024-10-15","type":"pipeline","source":"CodeBlue","summary":"Expert Foresees ‘Full Privatisation’ Of MOH’s FPP Service - CodeBlue","headline":"Expert Foresees ‘Full Privatisation’ Of MOH’s FPP Service","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPODFmbEtqVjJUYW1vTlplSDZUQldFYnZ3bVg5bjBSX0pJVWg3R2FfN192M09Sc2FlRzRfcGJyWnpnUXY0dDluREtHT09mM2xyTmFISU50aWJ6cEQ2TkJxQ1NJSWhNQk5FYi1CZEs3bjU5cGYwbzJZbVVoUWlaRmR1ekYwRWZ2QQ?oc=5","date":"2024-10-04","type":"pipeline","source":"CodeBlue","summary":"Private Wings, Public Concerns — Dr Richard - CodeBlue","headline":"Private Wings, Public Concerns — Dr Richard","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE44TnVoWEI4WkxaRTJRZjh0WUxEZkpmZkt6eWs5cDZmc0QxSXNWMXlWMTVUUUZILWhqQlBKcHBLODA4UDBNWWlSMkhzRHl2SzR4eVZ2Tw?oc=5","date":"2024-09-11","type":"deal","source":"bernama","summary":"UKM, Chempartner Join Forces In Revolutionising Modern Medical Science - bernama","headline":"UKM, Chempartner Join Forces In Revolutionising Modern Medical Science","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPRG9OLVRjeEN5WFkybEloSXNYWV8yaTJBaTFDOVBSWmQtdHVEWUk4c0M5Qy1OYlFIaWttZGd0azlNQkpvZHdUcW81RUxpREhFQmNabHpRcFE5ek1VMnZTLVFOeWRScHJTQkpJZjg2cVhSOWs1SGtJX3FnNDJNZTBER28xaGpWbnQyNk9VZ2JkbmVWV0E?oc=5","date":"2024-02-09","type":"pipeline","source":"Frontiers","summary":"Development and Validation of Adherence Score for Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs - Frontiers","headline":"Development and Validation of Adherence Score for Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOTG4wQi1xand0MmxHaWtqZTRVYXEzVDVVR2ViMFJ3alYycUl2YjAzRGc4c1l6UFNmWlBHQTd3bTRfek5vdHlEYVFXa3hYTjA4SFVrYkk2cGd3anN3ajNWR3g3M3ZOclQzZnpJdlg2VjZJenZ4aHE2YlNzTlo1cDJEVDd0SG1DeFB6OThrVTBTNzh3V3c0?oc=5","date":"2023-04-19","type":"trial","source":"Frontiers","summary":"Drug-related problems among transfusion-dependent thalassemia patients: A real-world evidence study - Frontiers","headline":"Drug-related problems among transfusion-dependent thalassemia patients: A real-world evidence study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE10QjBVRTdscklScldsd2s0M3BYVENTbkl3eTRydnNFUUlWMEZXblNZamV0N2Z2SVNIV0xPZFBod0J2OXhUT1FfaXVVZjd0T3RueFhsejlTNVpVUQ?oc=5","date":"2022-02-22","type":"pipeline","source":"bernama","summary":"Malaysia To Have Own Medical Town With UKM’s ‘Health Technopolis’ - bernama","headline":"Malaysia To Have Own Medical Town With UKM’s ‘Health Technopolis’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE9yRlk3N2ZXUWpfNERDWXFBa1pFOGNqTUJkM1dqdDlON2l1RC1wU0dlOTRFckIwSkQyR2hJbTNwb09waEhnUllvZHk5RVdvX0NqVmw4Qml1YURHTkF2OUdKc2JIOHpiS2o0TGs5S2xsT0ZwNU0?oc=5","date":"2021-06-23","type":"trial","source":"asiasentinel.com","summary":"Malaysia's Clinical Trials Quagmire - asiasentinel.com","headline":"Malaysia's Clinical Trials Quagmire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9ZYkd4LW80U0JCTlhqdVdBZjh3d3V1dEpUWkdBcVFLOE05cXExU1NSdzBSbFItclo2S0hCTkdwODJPcTl1NUFfcjFvWkI4bURsRkdrOFd4QkxnaFl0Q0lv?oc=5","date":"2021-05-31","type":"pipeline","source":"Nature","summary":"Comparison of sPLA2IIA performance with high-sensitive CRP neutrophil percentage PCT and lactate to identify bacterial infection - Nature","headline":"Comparison of sPLA2IIA performance with high-sensitive CRP neutrophil percentage PCT and lactate to identify bacterial i","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNYWFpSXhXVEhaTm5XdElfN1FSLUlXa1lMajNjYjVPQ19XTnppVGZ2TGRaZWtGRTZ2NGpDR2FIdUtVbVlyRlpERDBOS3hwZzZyaGFteGtpUDEwazE4SmNMcFdSRHVRNlZRaXd3RkVwVUtEemYyZTQ4NDR0UzZ1dnhSdEdhRnZGclhlN3lQeUtYRGtSSzEzbHJJSnQ1NGZ5bzVPdlZnaXM3YkZZUnd1UEZPRm5EaE9sMGZobGMteWJOSGhQY3FwZFBjRjhsYw?oc=5","date":"2020-12-08","type":"pipeline","source":"Dove Medical Press","summary":"Pharmacology and Pharmacokinetics of Vitamin E: Nanoformulations to Enhance Bioavailability - Dove Medical Press","headline":"Pharmacology and Pharmacokinetics of Vitamin E: Nanoformulations to Enhance Bioavailability","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFB2R3E2ZkZibEFUbEZ2WTBZX1g5b20tYldsN0wzWUI1LWVNOHVQRU5ucGhrUTAzU0hYWE4zVmpraFZwT3U4eGp3eHlkOGdVa1VWSzlLbkNMUGU2ZHdXX1Nv?oc=5","date":"2018-02-13","type":"pipeline","source":"Nature","summary":"Development of a bacterial cellulose-based hydrogel cell carrier containing keratinocytes and fibroblasts for full-thickness wound healing - Nature","headline":"Development of a bacterial cellulose-based hydrogel cell carrier containing keratinocytes and fibroblasts for full-thick","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":2,"phase_2":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}